BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1919745)

  • 21. Clinical utility of technetium-99m-teboroxime myocardial washout imaging.
    Henzlova MJ; Machac J
    J Nucl Med; 1994 Apr; 35(4):575-9. PubMed ID: 8151378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dipyridamole-induced vasodilation on myocardial uptake and clearance kinetics of thallium-201.
    Beller GA; Holzgrefe HH; Watson DD
    Circulation; 1983 Dec; 68(6):1328-38. PubMed ID: 6640881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between technetium-99m-teboroxime and thallium-201 dipyridamole planar myocardial perfusion imaging in detection of coronary artery disease.
    Labonté C; Taillefer R; Lambert R; Basile F; TonThat T; Jarry M; Léveillé J
    Am J Cardiol; 1992 Jan; 69(1):90-6. PubMed ID: 1729873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in myocardial perfusion imaging: 99mTc-teboroxime.
    Pieri PL; Strauss HW
    J Nucl Biol Med (1991); 1992; 36(2 Suppl):22-8. PubMed ID: 1450239
    [No Abstract]   [Full Text] [Related]  

  • 25. Myocardial technetium-99m-teboroxime activity in acute coronary artery occlusion and reperfusion: relation to myocardial blood flow and viability.
    Abraham SA; Mirecki FN; Levine D; Nunn AD; Strauss HW; Gewirtz H
    J Nucl Med; 1995 Jun; 36(6):1062-8. PubMed ID: 7769429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial uptake and kinetic properties of technetium-99m-Q3 in dogs.
    Gerson MC; Millard RW; McGoron AJ; Gabel M; Washburn LC; Biniakiewicz D; Elder RC; Deutsch E; Walsh RA
    J Nucl Med; 1994 Oct; 35(10):1698-706. PubMed ID: 7931674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.
    Berman DS; Kiat H; Maddahi J
    Circulation; 1991 Sep; 84(3 Suppl):I7-21. PubMed ID: 1832100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teboroxime, sestamibi and thallium-201 as markers of myocardial hypoperfusion: comparison by quantitative dual-isotope autoradiography in rabbits.
    Weinstein H; Reinhardt CP; Leppo JA
    J Nucl Med; 1993 Sep; 34(9):1510-7. PubMed ID: 8355072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic planar myocardial perfusion imaging in patients with one-vessel disease with intracoronary injection of technetium 99m teboroxime during papaverine-induced coronary hyperemia.
    Tartagni F; Fallani F; Corbelli C; Monetti N; Piovaccari G; Marzocchi A; Zannoli R; Branzi A; Magnani B; Heo J; Iskandrian AS
    Am Heart J; 1996 Nov; 132(5):1042-7. PubMed ID: 8892781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Myocardial scintigraphy with Tc-99m-teboroxime: its feasibility and the evaluation of its diagnostic reliability. A comparison with thallium-201 and coronary angiography].
    Bisi G; Sciagrà R; Santoro GM; Cerisano G; Vella A; Zerauschek F; Fazzini PF
    G Ital Cardiol; 1992 Jul; 22(7):795-805. PubMed ID: 1473653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of flow on technetium-99m-teboroxime (SQ30217) and thallium-201 extraction and retention in rabbit heart.
    Marshall RC; Leidholdt EM; Zhang DY; Barnett CA
    J Nucl Med; 1991 Oct; 32(10):1979-88. PubMed ID: 1919742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial extraction of teboroxime: effects of teboroxime interaction with blood.
    Rumsey WL; Rosenspire KC; Nunn AD
    J Nucl Med; 1992 Jan; 33(1):94-101. PubMed ID: 1530970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive evaluation of myocardial perfusion with use of technetium-99m teboroxime.
    McGhie AI; Willerson JT
    J Am Coll Cardiol; 1992 Sep; 20(3):720-1. PubMed ID: 1512354
    [No Abstract]   [Full Text] [Related]  

  • 34. Myocardial perfusion imaging with technetium-99m-teboroxime.
    Johnson LL
    J Nucl Med; 1994 Apr; 35(4):689-92. PubMed ID: 8151395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myocardial perfusion and clearance of 99mTc teboroxime assessed by SPECT].
    Nakajima K; Taki J; Bunko H; Taniguchi M; Shuke N; Kuji I; Hisada K; Shimizu M
    Kaku Igaku; 1992 Apr; 29(4):485-93. PubMed ID: 1602643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiological basis of myocardial perfusion imaging with the technetium 99m agents.
    Beller GA; Watson DD
    Semin Nucl Med; 1991 Jul; 21(3):173-81. PubMed ID: 1835136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial uptake and redistribution of 99mTc-N-NOET in dogs with either sustained coronary low flow or transient coronary occlusion: comparison with 201Tl and myocardial blood flow.
    Vanzetto G; Calnon DA; Ruiz M; Watson DD; Pasqualini R; Beller GA; Glover DK
    Circulation; 1997 Oct; 96(7):2325-31. PubMed ID: 9337207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Myocardial microcirculation in humans--new approaches using MRI].
    Wacker CM; Bauer WR
    Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different tracers and stressors in patients with coronary artery disease: how to standardize clinical questions and nuclear cardiology answers.
    Marzullo P; Sambuceti G; Gimelli A; Giorgetti A; Parodi O
    J Nucl Biol Med (1991); 1994 Dec; 38(4):566-72. PubMed ID: 7786918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow versus uptake comparisons of thallium-201 with technetium-99m perfusion tracers in a canine model of myocardial ischemia.
    Meleca MJ; McGoron AJ; Gerson MC; Millard RW; Gabel M; Biniakiewicz D; Roszell NJ; Walsh RA
    J Nucl Med; 1997 Dec; 38(12):1847-56. PubMed ID: 9430457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.